Wet Macular Degeneration  >>  Fumena (vorolanib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fumena (vorolanib) / Tyrogenex, Betta Pharma
NCT01674569: Pilot Study of X-82 in Patients With Wet AMD

Completed
1/2
35
US
X-82 oral, ranibizumab (Lucentis)
Tyrogenex
Exudative Macular Degeneration
02/15
02/15

Download Options